3030 — Test Research Cashflow Statement
0.000.00%
Last trade - 00:00- TWD22.06bn
- TWD20.76bn
- TWD4.44bn
- 82
- 38
- 70
- 74
Annual cashflow statement for Test Research, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,161 | 1,373 | 1,558 | 2,454 | 1,255 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -31.4 | -10.4 | -13.3 | -8.51 | -31.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 102 | -371 | -1,091 | -1,119 | 511 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,358 | 1,120 | 591 | 1,467 | 1,878 |
| Capital Expenditures | -53.7 | -52.6 | -155 | -680 | -877 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -192 | -3.93 | 46.7 | -74.6 | -181 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -246 | -56.5 | -108 | -754 | -1,058 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -898 | -806 | -807 | -814 | -1,098 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 203 | 260 | -335 | -77.7 | -289 |